What does a small retrolisthesis at L4‑L5 mean?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What Does Small Retrolisthesis at L4-L5 Mean?

A small retrolisthesis at L4-L5 means the L4 vertebra has slipped backward (posteriorly) relative to the L5 vertebra below it—typically defined as posterior translation of 2-3mm or more—and represents a common degenerative finding that often serves as a compensatory mechanism for sagittal spinal imbalance rather than true instability.

Understanding Retrolisthesis

Retrolisthesis is a form of vertebral misalignment where the upper vertebra shifts backward relative to the one below. At L4-L5, this is an extremely common finding:

  • Prevalence: Retrolisthesis is present in approximately 78-80% of patients undergoing lumbar fusion procedures, making it far more common than most clinicians realize 1, 2
  • Most common locations: L3-L4 and L2-L3, though L4-L5 is frequently affected 1
  • Often multilevel: Many patients have retrolisthesis at multiple levels simultaneously 1

Biomechanical Mechanism

Unlike anterolisthesis (forward slippage), retrolisthesis has a distinct biomechanical profile 3, 2, 4:

Key characteristics associated with retrolisthesis:

  • Reduced lumbar lordosis (flatter lower back curve)
  • Lower pelvic incidence (constitutional pelvic anatomy)
  • Thoracolumbar kyphosis (forward curve at the junction)
  • Reduced disc height at the affected level
  • Decreased endplate inclination

Critical distinction: Retrolisthesis appears to function as a compensatory mechanism to shift the body's center of gravity posteriorly when the spine cannot maintain proper sagittal balance through normal lordosis 2, 4. This is fundamentally different from anterolisthesis, which is associated with higher pelvic incidence and facet joint orientation abnormalities.

Clinical Significance

When Retrolisthesis Matters

The presence of retrolisthesis alone is NOT predictive of poor outcomes 1. However, certain patterns increase clinical concern:

Higher risk scenarios:

  • ≥3 levels of retrolisthesis: Associated with 3.65-5.50 times higher revision surgery risk after fusion 1
  • Severe disc degeneration at the retrolisthesis level 5, 6
  • Significant facet joint degeneration 5, 6
  • Paraspinal muscle atrophy (especially multifidus) 5, 6
  • High total endplate scores (degenerative endplate changes) 6

Symptoms

Retrolisthesis itself may be asymptomatic or associated with:

  • Low back pain (most common)
  • Radicular leg pain if nerve compression occurs
  • Neurogenic claudication if spinal stenosis develops
  • Typically does NOT cause neurological deficits unless severe stenosis present

Implications for Treatment

Conservative Management

For isolated small retrolisthesis at L4-L5 without significant symptoms:

  • Physical therapy focusing on core strengthening and lumbar stabilization
  • Paraspinal muscle strengthening (particularly multifidus) may be protective 5
  • Activity modification and pain management as needed

Surgical Considerations

Important context from guidelines 7:

  • Preoperative spondylolisthesis (including retrolisthesis) is identified as a risk factor for clinical failure after decompression alone
  • The incidence of progressive slippage after decompression ranges from 9% (without preop instability) to 73% (with preop spondylolisthesis)
  • However, this primarily refers to anterolisthesis data; retrolisthesis has different biomechanics

If surgery is being considered for stenosis at L4-L5 WITH retrolisthesis:

  • Fusion may be warranted in addition to decompression, particularly if:
    • Dynamic instability on flexion-extension films
    • Multilevel retrolisthesis (≥3 levels)
    • Severe disc and facet degeneration
    • Significant paraspinal muscle atrophy

Critical caveat: The SPORT trial 8 demonstrated superior outcomes with decompression and fusion for stenosis with spondylolisthesis, but surgeons were free to choose fusion technique. The presence of retrolisthesis specifically was not the primary focus.

Post-Surgical Implications

If you've already had lumbar fusion elsewhere and now have retrolisthesis at L4-L5:

Adjacent segment disease (ASD) with retrolisthesis 5, 6, 9:

  • Retrolisthesis is the most common pattern of ASD (61.8% of cases) 5
  • Risk factors include: reduced disc height, severe disc degeneration, facet degeneration, and multifidus atrophy
  • Symptomatic retrolisthesis requiring revision occurs in a subset of patients
  • Early muscle-strengthening exercises may be protective 5

Common Pitfalls to Avoid

  1. Don't assume retrolisthesis = instability: Unlike anterolisthesis, retrolisthesis often represents compensation, not pathologic instability
  2. Don't ignore multilevel involvement: Single-level retrolisthesis has different implications than ≥3 levels 1
  3. Don't overlook muscle quality: Paraspinal muscle atrophy is a key modifiable risk factor 5, 6
  4. Don't equate with anterolisthesis: These have opposite biomechanical drivers and different treatment implications 2, 4

Bottom Line

A small retrolisthesis at L4-L5 is a common degenerative finding that typically reflects the spine's attempt to maintain balance rather than true pathologic instability. Treatment decisions should be based on symptoms, associated stenosis, multilevel involvement, and degree of disc/facet degeneration—not the retrolisthesis alone. The presence of ≥3 levels of retrolisthesis or severe associated degeneration warrants closer monitoring and potentially more aggressive intervention if surgery becomes necessary.

References

Related Questions

What is the clinical significance of a 4 mm retrolisthesis?
In a patient with mild, asymptomatic lumbar retrolisthesis, are there any activity restrictions?
How should grade I retrolisthesis of L4–L5 be managed conservatively?
What is retrolisthesis and what are the recommended first‑line treatments?
What is the appropriate treatment for minimal C5‑6 retrolisthesis?
What is the appropriate management for a 45-year-old male with persistent nasal congestion and rhinorrhea after completing a course of antibiotics, given the absence of fever, headache, or facial pressure?
Can measles reactivate in a patient who is post‑chemotherapy and has recovered from dengue?
What are the contraindications to using hydralazine in a patient with acute intracerebral hemorrhage?
For a patient with type 1 diabetes currently on insulin glargine (Lantus) 18 U daily, daytime insulin‑sensitivity factor of 25 mg/dL per unit, overnight factor of 50 mg/dL per unit, and insulin‑to‑carbohydrate ratio of 1 U per 8 g, who ate 56 g carbohydrate at 14:00 with a blood glucose of 200 mg/dL at 16:00, then ate 82 g carbohydrate at 19:00 with a blood glucose of 199 mg/dL at 22:00, and had a blood glucose of 132 mg/dL at 04:00, what should the insulin glargine dose, insulin‑sensitivity factor, and insulin‑to‑carbohydrate ratio be adjusted to?
What low‑impact core‑strengthening and mobility exercises should a patient with a small L4‑L5 retrolisthesis who is currently asymptomatic perform to prevent future low‑back pain and improve long‑term outcomes?
If a patient starts escitalopram (Lexapro) 10 mg daily in early July, when should the follow‑up visits be scheduled?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.